Your browser doesn't support javascript.
loading
Corrigendum: Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients With Newly Diagnosed Glioblastoma: Subgroup Analysis of methe Phase 3 EF-14 Clinical Trial.
Ram, Zvi; Kim, Chae-Yong; Hottinger, Andreas F; Idbaih, Ahmed; Nicholas, Garth; Zhu, Jay-Jiguang.
Afiliación
  • Ram Z; Department of Neurosurgery, Tel Aviv Medical Center and Tel Aviv University School of Medicine, Tel Aviv, Israel.
  • Kim CY; Department of Neurosurgery, Seoul National University College of Medicine, Seoul, South Korea.
  • Hottinger AF; Department of Clinical Neuroscience, CHUV Lausanne University Hospital & University of Lausanne, Lausanne, Switzerland.
  • Idbaih A; Service de Neurologie 2-Mazarin, Sorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, Service de Neurologie 2-Mazarin, Paris, France.
  • Nicholas G; Department of Medicine, University of Ottawa, Ottawa, ON, Canada.
  • Zhu JJ; Department of Neurosurgery, University of Texas Health Science Center at Houston, Houston, TX, United States.
Front Oncol ; 12: 902929, 2022.
Article en En | MEDLINE | ID: mdl-35494031
[This corrects the article DOI: 10.3389/fonc.2021.671972.].
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article